Project Grant R01DA062639

Award Date 7/15/25
Completion Date 3/31/30
Dollars Obligated $764K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $423,447 to Brown University to investigate the impact of social-contextual stressors on smoking cessation and relapse among socioeconomically disadvantaged young adults (SDYA) who smoke cigarettes. The research aims to gain an in-depth understanding of how social-contextual stressors affect smoking cessation and relapse in SDYA through a...
The National Institute on Drug Abuse (NIDA) awarded a $1,076,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Dynamicare Health Inc. in Wareham, MA. The award will fund a Phase II randomized clinical trial to evaluate the efficacy of DCH-003, a digital therapeutic that delivers contingency management for the treatment of stimulant use disorder. The trial will compare standard clinic care plus DCH-003 to standard care plus a sham digital app, with the...
The National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 - Drug Use and Addiction Research Programs, awarded a $1,965,600 Project Grant to the Regents of the University of Colorado, doing business as the University of Colorado-Denver. The grant titled "Precision Pharmacogenomics and Indigenous Research: A Novel Approach to Tobacco Cessation Efficacy in American Indian Communities" aims to leverage genome-wide and epigenome-wide association studies to better understand the...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a multi-method study on momentary distress intolerance and its relationship to cigarette smoking among adults with emotional distress. The $233,913 award to Rutgers, The State University will fund a 5-year research plan involving qualitative investigation, ecological momentary assessment, and longitudinal modeling to better understand...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $241,500 to Duke University to examine the use of very low nicotine content (VLNC) cigarettes as a means to improve smoking cessation outcomes among individuals with opioid use disorder and chronic pain. The research will employ a randomized design to evaluate the effects of VLNC cigarettes versus normal nicotine content cigarettes on smoking...
The National Institute on Drug Abuse (NIDA) awarded a $283,968 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the Regents of the University of Michigan to build an "AI Forest" system for studying social and environmental factors that influence complex behavioral traits in a wild population of white-faced capuchin monkeys in Costa Rica. The project will leverage advanced technologies like deep learning algorithms and smart testing stations to automate data...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to validate a virtual reality-based attentional bias (VR-AB) marker as a biomarker for tobacco use disorder. The $1,766,843 award will fund a study to assess the VR-AB marker's reliability, its potential as a predictive biomarker for response to the smoking cessation medication varenicline, and its viability as a candidate surrogate endpoint. The...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $608,046 to Evidation Health, Inc. to develop a digital product called "Research and Engagement on Substance Use Harnessing Awareness and Personalized Education (RESHAPE)". The objective is to create a comprehensive digital experience to improve well-being and self-efficacy for individuals with substance use disorder (SUD) and...
This Project Grant award of $3,257,011 from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will fund a randomized controlled trial to evaluate the effectiveness of switching to electronic nicotine delivery systems (ENDS) compared to nicotine replacement therapy (NRT) for promoting smoking abstinence among individuals enrolled in substance use disorder (SUD) treatment programs in South Carolina. The study aims to: 1) assess...
This Project Grant award of $2,594,198.00 from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), supports research to elucidate the neural circuitry linked to smoking and the genetic influences on it. The study will use the UK Biobank neuroimaging dataset to examine habenula functional connectivity with the salience network and ventral tegmental area, and the influence of genomic variations on this connectivity. It will compare...

The National Institute on Drug Abuse (NIDA) awarded Duke University a Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate digital envirotyping methods for characterizing the everyday environments of people who smoke. The $763,766 award, which runs from July 2025 to March 2030, aims to (1) advance digital envirotyping and enviromarker development to identify environmental triggers of smoking relapse, and (2) increase understanding of environmental smoking risk factors in at-risk populations. The project will recruit 500 adults interested in quitting smoking and use photographic ecological momentary assessment to collect over 300,000 images of their environments before and during their quit attempt. Computer vision and artificial intelligence will be leveraged to extract detailed environmental information and develop enviromarkers predictive of smoking relapse risk.

Generated 8/5/25, 2:53 AM